Status:
COMPLETED
Multiplexing Prism Fitting for Field Expansion of Monocular Vision
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
One Eye Blindness
Blind Left Eye
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators are ...
Eligibility Criteria
Inclusion
- No medical health issues such as seizures, motor movements problem
- Loss of vision in one eye (less than 20/200) for \>1 year)
- Visual acuity of the seeing eye: Better than 20/32 visual acuity with correction
- No visual field defect in the seeing eye (nasal field of at least \>45degree)
- No medical health issues such as seizures, motor movements problem
Exclusion
- Patients with any physical or mental disabilities, including cognitive dysfunction, balance problems, or other deficits that could impair their ability to respond to the stimuli presented in this study will be excluded
- Any person with motor movements problem (e.g., unable to use extremities)
Key Trial Info
Start Date :
December 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06027216
Start Date
December 27 2023
End Date
December 31 2024
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schepens Eye Research Institute
Boston, Massachusetts, United States, 02114